Recorded fact · drug.trial_access
drug.trial_access for etanercept
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 024989c7 resolves to.
The record
| Fact id | 024989c700d51e005ae9f8da |
|---|---|
| Entity | drug: etanercept |
| Field | drug.trial_access |
| Source | clinicaltrials.gov |
| Read on | 2026-11-07T06:34:32.466Z |
| Source version | clinicaltrials-api-2.0.5-data-2026-11-06T10:00:05 |
| Method | api |
| Verification | machine_read |
| Licence | Terms and Conditions (last updated 2023-01-31) READ in full 2026-11-07: data free to all requesters; reuse allowed on conditions: attribute ClinicalTrials.gov, keep data current, display the date the registry processed the data, state any modifications; do not represent the data as other than a US Government database; no use of extracted email addresses for marketing; some records may carry third-party copyright (consult the submitter) and the data carry an international copyright outside the US. API rate guidance page UNREAD (JS page rendered no text 2026-11-07). AMBER because of the third-party copyright caveat on submitter text; counts and ids are safe, long free text is not reproduced. | DISPLAY CONDITIONS (any page or delivery using this source): attribute ClinicalTrials.gov, show the registry processing date, state our modifications, never present as other than a US Government database, never use extracted emails for marketing. |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
This fact carries no verifying quote; its source is the dataset named above.
The value
{
"ingredient": "ETANERCEPT",
"recruitingInterventionalCount": 13,
"notYetRecruitingCount": 2,
"byPhase": {
"PHASE3": 2,
"PHASE2": 1,
"NA": 2,
"PHASE1": 1,
"PHASE2/PHASE3": 1,
"PHASE4": 6
},
"trials": [
{
"nctId": "NCT06654882",
"briefTitle": "Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis",
"phase": [
"PHASE3"
],
"leadSponsor": "Duke University",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2026-10-21",
"startDate": "2026-01-09",
"conditions": [
"Polyarticular Course Juvenile Idiopathic Arthritis (JIA)"
],
"countries": [
"United States",
"Germany",
"Italy",
"Netherlands"
],
"url": "https://clinicaltrials.gov/study/NCT06654882"
},
{
"nctId": "NCT07138898",
"briefTitle": "Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty",
"phase": [
"PHASE2"
],
"leadSponsor": "NYU Langone Health",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2026-07-09",
"startDate": "2025-12-12",
"conditions": [
"Rheumatic Disease"
],
"countries": [
"United States"
],
"url": "https://clinicaltrials.gov/study/NCT07138898"
},
{
"nctId": "NCT07184853",
"briefTitle": "Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD",
"phase": [
"NA"
],
"leadSponsor": "First Affiliated Hospital of Zhejiang University",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2026-07-07",
"startDate": "2025-09-25",
"conditions": [
"Graft vs Host Disease"
],
"countries": [
"China"
],
"url": "https://clinicaltrials.gov/study/NCT07184853"
},
{
"nctId": "NCT03414502",
"briefTitle": "Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response",
"phase": [
"PHASE3"
],
"leadSponsor": "University of Nebraska",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2026-06-17",
"startDate": "2007-12-10",
"conditions": [
"Rheumatoid Arthritis"
],
"countries": [
"United States"
],
"url": "https://clinicaltrials.gov/study/NCT03414502"
},
{
"nctId": "NCT06585384",
"briefTitle": "Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease",
"phase": [
"PHASE1"
],
"leadSponsor": "Fondation Ophtalmologique Adolphe de Rothschild",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2026-05-12",
"startDate": "2025-04-15",
"conditions": [
"Alzheimer Disease"
],
"countries": [
"France"
],
"url": "https://clinicaltrials.gov/study/NCT06585384"
},
{
"nctId": "NCT06011889",
"briefTitle": "Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome",
"phase": [
"PHASE2",
"PHASE3"
],
"leadSponsor": "National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2026-04-13",
"startDate": "2024-09-04",
"conditions": [
"SAPHO Syndrome"
],
"countries": [
"Poland"
],
"url": "https://clinicaltrials.gov/study/NCT06011889"
},
{
"nctId": "NCT05305066",
"briefTitle": "Stand UP to Rheumatoid Arthritis (SUPRA)",
"phase": [
"NA"
],
"leadSponsor": "Marie Hudson, MD",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2026-02-03",
"startDate": "2023-02-01",
"conditions": [
"Rheumatoid Arthritis"
],
"countries": [
"Canada"
],
"url": "https://clinicaltrials.gov/study/NCT05305066"
},
{
"nctId": "NCT07149792",
"briefTitle": "A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers",
"phase": [
"PHASE4"
],
"leadSponsor": "Taichung Veterans General Hospital",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2025-09-02",
"startDate": "2025-07-29",
"conditions": [
"Psoriasis",
"Psoriasis Arthritis",
"Biologics"
],
"countries": [
"Taiwan"
],
"url": "https://clinicaltrials.gov/study/NCT07149792"
},
{
"nctId": "NCT04985435",
"briefTitle": "Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)",
"phase": [
"PHASE4"
],
"leadSponsor": "R.Bos",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2025-08-08",
"startDate": "2021-05-12",
"conditions": [
"Rheumatoid Arthritis"
],
"countries": [
"Netherlands"
],
"url": "https://clinicaltrials.gov/study/NCT04985435"
},
{
"nctId": "NCT06707194",
"briefTitle": "Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis",
"phase": [
"PHASE4"
],
"leadSponsor": "Nanfang Hospital, Southern Medical University",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2025-06-26",
"startDate": "2025-06-14",
"conditions": [
"Spondyloarthritis (SpA)",
"Ankylosing Spondylitis (AS)"
],
"countries": [
"China"
],
"url": "https://clinicaltrials.gov/study/NCT06707194"
},
{
"nctId": "NCT02714634",
"briefTitle": "Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide",
"phase": [
"PHASE4"
],
"leadSponsor": "University Hospital, Strasbourg, France",
"overallStatus": "RECRUITING",
"lastUpdatePostDate": "2025-03-12",
"startDate": "2016-03-30",
"conditions": [
"Rheumatoid Arthritis",
"Insufficient Response to Methotrexate or Leflunomide"
],
"countries": [
"France"
],
"url": "https://clinicaltrials.gov/study/NCT02714634"
},
{
"nctI
... (shortened here; the full value is in the JSON twin)SHA-256 of the exact stored value: 85a0520be024956cee45fc693181b49804c9cbe138c4e31cfa0064cb9181c48e.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.